Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Erzincan Üniversitesi, Turkey

Dr. Ahmet Altay is an accomplished researcher and academic in the field of chemistry, specializing in biochemistry, medicinal chemistry, and interdisciplinary sciences. With a strong background in natural product chemistry and anticancer drug discovery, he has contributed significantly to the scientific community through his research on antioxidants, cytotoxic agents, and enzyme inhibition. His extensive publication record in high-impact SCI-Expanded journals highlights his expertise in experimental and computational studies. Currently serving as an Associate Professor at Erzincan Binali Yıldırım University, Dr. Altay continues to push the boundaries of chemical and biochemical research, focusing on novel therapeutic compounds and their biological applications.

Professional Profile 

Education

Dr. Ahmet Altay earned his Ph.D. in Biochemistry from Middle East Technical University (METU), Turkey, in 2015. His doctoral research focused on the antioxidant and cytotoxic properties of Salvia fruticosa M., as well as its effects on cytochrome P450 enzymes and antioxidant gene expression in colon cancer cells.

Professional Experience

Dr. Altay has been a faculty member at Erzincan Binali Yıldırım University since 2016. He started as an Assistant Professor (2016-2018), was promoted to Associate Professor in 2020, and has since been actively involved in research and teaching. His work spans multiple disciplines within chemistry and biochemistry, with a strong focus on drug discovery and molecular interactions. His contributions include supervising graduate students, securing research grants, and collaborating on international scientific projects.

Research Interests

Dr. Ahmet Altay’s research interests lie at the intersection of biochemistry, medicinal chemistry, and pharmacology, with a particular focus on drug discovery and natural product chemistry. His work extensively explores the antioxidant, anticancer, and enzyme-inhibitory properties of bioactive compounds derived from medicinal plants. He is also deeply engaged in molecular docking studies to understand drug-receptor interactions at a computational level. Additionally, his research investigates apoptosis mechanisms, oxidative stress-related disorders, and the modulation of key metabolic pathways in cancer and neurodegenerative diseases. By integrating experimental and computational approaches, Dr. Altay aims to develop novel therapeutic agents that can target cancer, microbial infections, and enzyme-related disorders. His interdisciplinary research combines chemical synthesis, molecular modeling, and pharmacological evaluation to provide innovative solutions in biomedical sciences.

Awards and Honors

Dr. Ahmet Altay has received multiple awards and recognitions for his outstanding contributions to scientific research and academia. His excellence in publishing high-impact research has been acknowledged with best paper awards and recognitions from international conferences and scientific organizations. He has been honored with research grants and funding support for his projects on natural product chemistry and drug discovery. As an active academic, he has also received accolades for his contributions to student mentorship and scientific collaboration. His efforts in cancer research and enzyme inhibition studies have been recognized by national and international institutions. Additionally, his role as a peer reviewer and editorial board member in prestigious scientific journals highlights his expertise and influence in the field. These awards and honors underscore his dedication to advancing biomedical and pharmaceutical sciences.

Research Skills

Dr. Ahmet Altay possesses a diverse set of research skills spanning experimental and computational methodologies. His expertise includes the isolation and structural characterization of bioactive natural products using advanced chromatographic and spectroscopic techniques such as HPLC, GC-MS, and NMR. He is highly proficient in molecular docking, molecular dynamics simulations, and in silico drug design to predict ligand-target interactions. His skills in biochemical assays enable the evaluation of antioxidant, antimicrobial, and anticancer activities of synthetic and natural compounds. Additionally, he has extensive experience in enzyme kinetics, apoptosis studies, and gene expression analysis using RT-PCR and Western blot techniques. His interdisciplinary knowledge allows him to integrate synthetic chemistry, pharmacology, and bioinformatics to address complex biomedical challenges. Dr. Altay’s strong analytical skills, coupled with his experience in mentoring and collaboration, make him a leading researcher in his field.

Conclusion

Dr. Ahmet Altay is a strong candidate for the Best Researcher Award due to his high research output, international collaborations, and contributions to anticancer and biochemical research. To enhance his profile further, he could focus on leading large-scale projects, securing more grants, and publishing in top-tier journals. Nonetheless, his achievements make him a compelling nominee for this award.

Publications Top Noted

  • Title: Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1

    • Authors: Emine Karaca Sulukoğlu, Şükran Günaydın, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2024
    • Citation: Naunyn-Schmiedeberg’s Archives of Pharmacology
    • DOI: 10.1007/s00210-024-02980-5

  • Title: The Combined Effect of Vulpinic Acid and Doxorubicin in Breast Cancer MCF-7 Cells

    • Authors: Esma Kübra Kağan Yeniçeri, Ahmet Altay
    • Year: 2024
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1376859

  • Title: Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells

    • Authors: Şükran Günaydın, Emine Karaca Sulukoğlu, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4505

  • Title: Effect of evernic acid on human breast cancer MCF‐7 and MDA‐MB‐453 cell lines via thioredoxin reductase 1: A molecular approach

    • Authors: Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4451

  • Title: In Vitro Cytotoxic Evaluation of a Silver(I) Complex Including Non-Steroidal Anti-Inflammatory Drug Niflumic Acid and 3-Picoline on Human-Derived Cancer Cell Lines

    • Authors: Sema Çağlar, Ahmet Altay, Bülent Çağlar, Esma Kübra Kağan Yeniçeri, Betül Harurluoğlu
    • Year: 2022
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1130634

  • Title: A Biochemical Approach for Hedysarum candidissimum from Turkey: Screening Phytochemicals, Evaluation of Biological Activities, and Molecular Docking Study

    • Authors: Ahmet Altay, Esma Yeniceri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yilmaz, Ekrem Koksal
    • Year: 2022
    • Citation: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202200348

  • Title: Phytochemical Analysis and Biological Evaluation of Hypericum linarioides Bosse: in Vitro and in Silico Studies

    • Authors: Ahmet Altay, Esma Kübra Kağan Yeniçeri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yılmaz, Ekrem Köksal
    • Year: 2022
    • Citation: ChemistrySelect
    • DOI: 10.1002/slct.202200039

Kannan Pandian | Agricultural and Biological Sciences | Best Researcher Award

Posted on by ScienceFather

Dr. Kannan Pandian | Agricultural and Biological Sciences | Best Researcher Award

Associate Professor at Tamil Nadu Agricultural University, India

Dr. Kannan Pandian is an accomplished researcher in Soil Science and Agricultural Chemistry with expertise in dryland soil resource management, carbon sequestration, and nutrient efficiency enhancement. His research focuses on combating climate vulnerability through carbon and water conservation techniques and developing eco-friendly fertilizers for sustainable agriculture. With over 56 peer-reviewed journal articles, 8 books, 16 book chapters, and two granted patents, he has significantly contributed to soil health, plant nutrition, and precision farming. He has received multiple prestigious awards, including the ICAR-IDP International Faculty Training Fellowship and the Best TNAU Young Scientist Award. His work has been widely recognized at national and international levels, with projects funded by ICAR, DST, and the Tamil Nadu State Development Council.

Professional Profile 

Education

Dr. Kannan Pandian earned his Ph.D. in Soil Science and Agricultural Chemistry from Tamil Nadu Agricultural University (TNAU), Coimbatore, India, in 2007. He completed his Master of Science in the same field from TNAU in 2004 and obtained his Bachelor of Science in Agriculture from TNAU in 2002. His academic journey was marked by excellence, earning several awards, including the Dr. K.K. Krishnamurthy and Dr. G. Selvakumari Medal for Best Doctoral Student and the Prof. T. Balakrishnan Medal for Best Master’s Student. Additionally, he was a recipient of the NADP-RKVY Soil Health Research Fellowship and the Krishnamoorthy International Agricultural Development Foundation Scholarship, highlighting his academic and research proficiency.

Professional Experience

Dr. Kannan Pandian currently serves as an Associate Professor at the Department of Soils and Environment, Tamil Nadu Agricultural University (TNAU). Previously, he held positions as an Assistant Professor at TNAU, a Scientist at the Indian Council of Agricultural Research (ICAR), a Research Associate at the Centre for Soil and Crop Management Studies (CSCMS), and a Senior Research Fellow at TNAU. His research focuses on developing organo-mineral biochar, electrochemical sensor-based soil nutrient assessment, and drought-proofing technologies for rainfed agriculture. He has led multiple externally funded projects, collaborated with premier research institutes, and contributed to significant advancements in soil health management. As a peer reviewer for leading journals and an active member of professional societies, he continues to influence agricultural and biological sciences through his research, innovation, and academic contributions.

Research Interests

Dr. Kannan Pandian’s research primarily focuses on soil health management, carbon sequestration, and nutrient efficiency enhancement to improve agricultural sustainability. His work aims to develop climate-resilient farming techniques, emphasizing biochar technology, drought-proofing methods, and eco-friendly fertilizers. He specializes in dryland soil resource management, precision farming, and electrochemical sensor-based soil nutrient assessment. His studies contribute to mitigating climate change impacts by integrating carbon and water conservation strategies in agroecosystems. Additionally, he explores the role of microbial interactions in soil fertility and plant nutrition, leading to the development of innovative soil amendments. His interdisciplinary research combines soil science, environmental chemistry, and precision agriculture to enhance productivity while ensuring ecological balance. Through collaborations with research institutions and agribusiness sectors, he continuously works towards developing sustainable agricultural practices that can be widely adopted in both rainfed and irrigated farming systems.

Awards and Honors

Dr. Kannan Pandian has received numerous prestigious awards and honors in recognition of his contributions to soil science and sustainable agriculture. He was honored with the Best Young Scientist Award by Tamil Nadu Agricultural University (TNAU) for his innovative work on climate-resilient soil management. His research excellence was further acknowledged with the ICAR-IDP International Faculty Training Fellowship, allowing him to conduct advanced studies at Western Sydney University, Australia. He has also been awarded the Dr. APJ Abdul Kalam Best Teacher Award for his exceptional mentorship and academic contributions. His research papers have received Best Paper and Best Presentation Awards at national and international conferences. Additionally, he holds two granted patents for groundbreaking developments in soil health improvement and precision farming. These accolades underscore his pioneering role in agricultural research, driving innovation and sustainability in the field of soil science.

Research Skills

Dr. Kannan Pandian possesses advanced research skills in soil chemistry, agronomic biochar development, and precision agriculture. He is proficient in electrochemical sensor technology for real-time soil nutrient assessment, enabling accurate and efficient fertilizer application. His expertise in carbon sequestration and climate-smart agriculture allows him to develop strategies for mitigating greenhouse gas emissions in farmlands. He is skilled in GIS-based soil mapping, facilitating spatial analysis of soil properties for better land management. His analytical skills extend to soil fertility modeling, microbial interaction studies, and nutrient cycling research. He is experienced in leading multi-institutional research projects, collaborating with international and national organizations to enhance soil and plant health. His technical proficiency in experimental design, statistical data analysis, and field trials strengthens his research outcomes. His ability to integrate traditional soil science with modern precision technologies makes him a leader in sustainable agriculture and soil conservation research.

Conclusion

Dr. Kannan Pandian is an exceptional candidate for the Best Researcher Award, given his extensive contributions to soil science, sustainable agriculture, and climate resilience. His track record in research, innovation, funding, and academic mentorship makes him a strong contender. Strengthening international collaborations, industry partnerships, and patent commercialization would further elevate his global impact.

Publications Top Noted

  • Towards an operational SAR-based rice monitoring system in Asia: Examples from 13 demonstration sites across Asia in the RIICE project
    Authors: A Nelson, T Setiyono, AB Rala, ED Quicho, JV Raviz, PJ Abonete, …
    Year: 2014
    Citations: 197

  • Effect of biochar amendment on soil physical, chemical and biological properties and groundnut yield in rainfed Alfisol of semi-arid tropics
    Authors: K Pandian, P Subramaniayan, P Gnasekaran, S Chitraputhirapillai
    Year: 2016
    Citations: 178

  • Zinc deficiency in Indian soils with special focus to enrich zinc in peanut
    Authors: P Arunachalam, P Kannan, G Prabukumar, M Govindaraj
    Year: 2013
    Citations: 99

  • Biochar from green waste for phosphate removal with subsequent disposal
    Authors: DK Veni, P Kannan, TNJI Edison, A Senthilkumar
    Year: 2017
    Citations: 94

  • Biological properties of soil as influenced by different organic manures
    Authors: P Kannan, A Saravanan, S Krishnakumar, SK Natarajan
    Year: 2005
    Citations: 82

  • Applying both biochar and phosphobacteria enhances Vigna mungo L. growth and yield in acid soils by increasing soil pH, moisture content, microbial growth and P availability
    Authors: P Kannan, M Paramasivan, S Marimuthu, C Swaminathan, J Bose
    Year: 2021
    Citations: 73

  • Drought assessment and monitoring through remote sensing and GIS in western tracts of Tamil Nadu, India
    Authors: D Muthumanickam, P Kannan, R Kumaraperumal, S Natarajan, …
    Year: 2011
    Citations: 57

  • Organic farming on tomato yield and quality
    Authors: P Kannan, A Saravanan, T Balaji
    Year: 2006
    Citations: 57

  • Rice crop monitoring and yield estimation through COSMO Skymed and TerraSAR-X: A SAR-based experience in India
    Authors: S Pazhanivelan, P Kannan, P Christy Nirmala Mary, E Subramanian, …
    Year: 2015
    Citations: 38

  • Implication of micronutrients in agriculture and health with special reference to iron and zinc
    Authors: M Govindaraj, P Kannan, P Arunachalam
    Year: 2011
    Citations: 36

Laura Brannelly | Agricultural and Biological Sciences | Best Researcher Award

Posted on by ScienceFather

Dr. Laura Brannelly | Agricultural and Biological Sciences | Best Researcher Award

Senior Lecturer at University of Melbourne, Australia

Dr. Laura A. Brannelly is a Senior Lecturer in One Health and Biostatistics at the University of Melbourne’s Veterinary School, specializing in disease ecology, amphibian conservation, and the impacts of climate change on wildlife health. She earned her Ph.D. in Public Health, Medical, and Veterinary Sciences from James Cook University, focusing on chytridiomycosis in frogs. Her extensive research experience includes postdoctoral positions funded by the U.S. Department of Defense and the Australian Research Council, investigating amphibian reproduction, pathogen susceptibility, and environmental stressors. Dr. Brannelly is highly skilled in molecular biology, statistical modeling, ecological monitoring, and laboratory infection trials. She has mentored numerous graduate students and coordinated courses in research methods and conservation science. A sought-after speaker, she has presented her work internationally, contributing significantly to wildlife disease management and ecological research. Her work bridges scientific discovery and conservation, addressing pressing global challenges in biodiversity and environmental health.

Professional Profile

Education

Dr. Laura A. Brannelly holds a Ph.D. in Public Health, Medical, and Veterinary Sciences from James Cook University, where she focused on the effects of chytridiomycosis on amphibian populations. Prior to her doctoral studies, she earned a Bachelor of Science degree in Ecology and Evolutionary Biology from the University of Colorado Boulder. Her academic journey has been marked by a strong interdisciplinary approach, integrating ecology, disease dynamics, and conservation biology. During her Ph.D., she conducted extensive field and laboratory research on amphibian disease ecology, contributing valuable insights into wildlife health. Following her doctorate, she pursued postdoctoral research funded by the U.S. Department of Defense and the Australian Research Council, further refining her expertise in epidemiology, ecological modeling, and conservation strategies. Her educational background has provided her with a solid foundation in biostatistics, molecular biology, and ecological monitoring, shaping her career as a leading researcher in wildlife disease ecology.

Professional Experience

Dr. Laura A. Brannelly is a distinguished researcher specializing in wildlife disease ecology, with extensive experience in academia and scientific research. She has held research and faculty positions at leading institutions, including the University of Melbourne, where she investigates amphibian disease dynamics and conservation strategies. Her professional journey includes postdoctoral research funded by the U.S. Department of Defense and the Australian Research Council, focusing on the epidemiology of chytridiomycosis in amphibian populations. She has conducted field research in Australia, Central America, and the United States, collaborating with conservation organizations and government agencies to develop strategies for mitigating disease impacts on biodiversity. Dr. Brannelly is also an active mentor, supervising graduate students and contributing to curriculum development in ecological and veterinary sciences. Her work integrates molecular biology, epidemiology, and ecological modeling to advance conservation efforts and inform policy decisions on wildlife health management globally.

Research Interest

Dr. Laura A. Brannelly’s research focuses on wildlife disease ecology, with a particular emphasis on amphibian health and conservation. She investigates the epidemiology and impact of infectious diseases, such as chytridiomycosis, on amphibian populations worldwide. Her work integrates field studies, laboratory experiments, and ecological modeling to understand disease transmission, host-pathogen interactions, and the environmental factors influencing outbreaks. Dr. Brannelly is especially interested in how amphibian immune responses and life history traits affect disease susceptibility and recovery. She also explores conservation strategies, including disease mitigation, captive breeding programs, and habitat management, to support declining species. By collaborating with global conservation organizations and governmental agencies, she contributes to policies aimed at protecting biodiversity. Her interdisciplinary approach bridges ecology, immunology, and microbiology, providing critical insights into wildlife disease dynamics and informing effective conservation interventions for threatened species.

Research Skill

Dr. Laura A. Brannelly possesses a diverse set of research skills focused on disease ecology, amphibian conservation, and wildlife health. She is highly skilled in experimental design, fieldwork, and laboratory techniques, particularly in studying amphibian disease dynamics, host-pathogen interactions, and conservation interventions. Her expertise includes molecular diagnostics, histopathology, and microbiome analysis to investigate the effects of fungal pathogens such as Batrachochytrium dendrobatidis (chytrid fungus) on amphibian populations. Dr. Brannelly is proficient in statistical modeling and data analysis, employing advanced ecological and epidemiological modeling techniques to assess disease impacts and predict population trends. She is also adept at designing and implementing conservation management strategies, collaborating with governmental and non-governmental organizations to develop effective interventions. Additionally, her strong communication and public engagement skills allow her to translate complex scientific findings into actionable conservation policies. Her multidisciplinary research approach contributes significantly to amphibian conservation and global efforts to mitigate wildlife diseases.

Conclusion

Dr. Laura A. Brannelly is highly suitable for the Best Researcher Award, given her exceptional research track record, leadership, and contributions to disease ecology and amphibian conservation. Minor improvements in research dissemination and interdisciplinary collaborations could further elevate her profile.

Publications Top Noted

  • Title: Chytrid fungus Batrachochytrium dendrobatidis has nonamphibian hosts and releases chemicals that cause pathology in the absence of infection
    Authors: TA McMahon, LA Brannelly, MWH Chatfield, PTJ Johnson, MB Joseph, …
    Year: 2013
    Citations: 262

  • Title: Susceptibility of amphibians to chytridiomycosis is associated with MHC class II conformation
    Authors: A Bataille, SD Cashins, L Grogan, LF Skerratt, D Hunter, M McFadden, …
    Year: 2015
    Citations: 173

  • Title: After the epidemic: ongoing declines, stabilizations and recoveries in amphibians afflicted by chytridiomycosis
    Authors: BC Scheele, LF Skerratt, LF Grogan, DA Hunter, N Clemann, …
    Year: 2017
    Citations: 153

  • Title: Low impact of chytridiomycosis on frog recruitment enables persistence in refuges despite high adult mortality
    Authors: BC Scheele, DA Hunter, LF Skerratt, LA Brannelly, DA Driscoll
    Year: 2015
    Citations: 101

  • Title: Priorities for management of chytridiomycosis in Australia: saving frogs from extinction
    Authors: LF Skerratt, L Berger, N Clemann, DA Hunter, G Marantelli, DA Newell, …
    Year: 2016
    Citations: 98

  • Title: Clinical trials with itraconazole as a treatment for chytrid fungal infections in amphibians
    Authors: LA Brannelly, CL Richards-Zawacki, AP Pessier
    Year: 2012
    Citations: 93

  • Title: A review of the role of parasites in the ecology of reptiles and amphibians
    Authors: DS Bower, LA Brannelly, CA McDonald, RJ Webb, SE Greenspan, …
    Year: 2019
    Citations: 92

  • Title: Reservoir‐host amplification of disease impact in an endangered amphibian
    Authors: BC Scheele, DA Hunter, LA Brannelly, LF Skerratt, DA Driscoll
    Year: 2017
    Citations: 91

  • Title: Amphibians with infectious disease increase their reproductive effort: evidence for the terminal investment hypothesis
    Authors: LA Brannelly, R Webb, LF Skerratt, L Berger
    Year: 2016
    Citations: 69

  • Title: Batrachochytrium dendrobatidis in natural and farmed Louisiana crayfish populations: prevalence and implications
    Authors: LA Brannelly, TA McMahon, M Hinton, D Lenger, CL Richards-Zawacki
    Year: 2015
    Citations: 69

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Posted on by ScienceFather

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional Profile 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short